Target Price | $160.47 |
Price | $114.50 |
Potential | 40.15% |
Number of Estimates | 55 |
55 Analysts have issued a price target NVIDIA 2026 . The average NVIDIA target price is $160.47. This is 40.15% higher than the current stock price. The highest price target is $235.92 106.04% , the lowest is $100.00 12.66% . | |
A rating was issued by 69 analysts: 60 Analysts recommend NVIDIA to buy, 8 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the NVIDIA stock has an average upside potential 2026 of 40.15% . Most analysts recommend the NVIDIA stock at Purchase. |
57 Analysts have issued a sales forecast NVIDIA 2026 . The average NVIDIA sales estimate is $201b . This is 54.10% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $246b 88.15% , the lowest is $171b 30.68% .
This results in the following potential growth metrics:
2025 | $130b | 114.20% |
---|---|---|
2026 | $201b | 54.10% |
2027 | $248b | 23.36% |
2028 | $290b | 16.75% |
2029 | $306b | 5.62% |
2030 | $309b | 1.13% |
20 Analysts have issued an NVIDIA EBITDA forecast 2026. The average NVIDIA EBITDA estimate is $127b . This is 52.60% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $144b 73.10% , the lowest is $110b 32.53% .
This results in the following potential growth metrics and future EBITDA Margins:
2025 | $83.3b | 141.64% |
---|---|---|
2026 | $127b | 52.60% |
2027 | $163b | 28.38% |
2028 | $186b | 14.09% |
2029 | $228b | 22.45% |
2025 | 63.85% | 12.81% |
---|---|---|
2026 | 63.22% | 0.98% |
2027 | 65.80% | 4.08% |
2028 | 64.30% | 2.28% |
2029 | 74.54% | 15.93% |
32 NVIDIA Analysts have issued a net profit forecast 2026. The average NVIDIA net profit estimate is $104b . This is 44.65% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $130b 81.29% , the lowest is $88.6b 23.13% .
This results in the following potential growth metrics and future Net Margins:
2025 | $72.0b | 147.06% |
---|---|---|
2026 | $104b | 44.65% |
2027 | $134b | 28.85% |
2028 | $157b | 17.01% |
2025 | 55.14% | 15.34% |
---|---|---|
2026 | 51.76% | 6.14% |
2027 | 54.06% | 4.44% |
2028 | 54.18% | 0.22% |
32 Analysts have issued a NVIDIA forecast for earnings per share. The average NVIDIA EPS is $4.25 . This is 44.56% higher than earnings per share in the financial year 2025. The highest EPS forecast is $5.33 81.29% , the lowest is $3.62 23.13% .
This results in the following potential growth metrics and future valuations:
2025 | $2.94 | 147.06% |
---|---|---|
2026 | $4.25 | 44.56% |
2027 | $5.48 | 28.94% |
2028 | $6.41 | 16.97% |
Current | 38.95 | 47.01% |
---|---|---|
2026 | 26.92 | 30.89% |
2027 | 20.90 | 22.36% |
2028 | 17.86 | 14.55% |
Based on analysts' sales estimates for 2026, the NVIDIA stock is valued at an EV/Sales of 13.73 and an P/S ratio of 13.89 .
This results in the following potential growth metrics and future valuations:
Current | 21.16 | 39.95% |
---|---|---|
2026 | 13.73 | 35.12% |
2027 | 11.13 | 18.94% |
2028 | 9.53 | 14.35% |
2029 | 9.02 | 5.33% |
2030 | 8.92 | 1.12% |
Current | 21.41 | 39.67% |
---|---|---|
2026 | 13.89 | 35.11% |
2027 | 11.26 | 18.94% |
2028 | 9.65 | 14.35% |
2029 | 9.13 | 5.33% |
2030 | 9.03 | 1.12% |
Analyst | Rating | Action | Date |
---|---|---|---|
Seaport Global |
➜
Sell
|
Initiated | Apr 30 2025 |
Morgan Stanley |
Overweight
➜
Overweight
|
Unchanged | Apr 25 2025 |
Barclays |
Overweight
➜
Overweight
|
Unchanged | Apr 22 2025 |
UBS |
Buy
➜
Buy
|
Unchanged | Apr 17 2025 |
Raymond James |
Strong Buy
➜
Strong Buy
|
Unchanged | Apr 16 2025 |
B of A Securities |
Buy
➜
Buy
|
Unchanged | Apr 16 2025 |
Cantor Fitzgerald |
Overweight
➜
Overweight
|
Unchanged | Apr 16 2025 |
Analyst Rating | Date |
---|---|
Initiated
Seaport Global:
➜
Sell
|
Apr 30 2025 |
Unchanged
Morgan Stanley:
Overweight
➜
Overweight
|
Apr 25 2025 |
Unchanged
Barclays:
Overweight
➜
Overweight
|
Apr 22 2025 |
Unchanged
UBS:
Buy
➜
Buy
|
Apr 17 2025 |
Unchanged
Raymond James:
Strong Buy
➜
Strong Buy
|
Apr 16 2025 |
Unchanged
B of A Securities:
Buy
➜
Buy
|
Apr 16 2025 |
Unchanged
Cantor Fitzgerald:
Overweight
➜
Overweight
|
Apr 16 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.